Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Multicenter Trial to Evaluate Real-world Health Outcomes and Economic Impact of Panitumumab Versus Standard-of-care in the Treatment of Patients With Chemotherapy-refractory Metastatic Colorectal Cancer

NCT02139215 is registered in ClinicalTrials.gov with PeriPharm as lead sponsor.

NCT NCT02139215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02139215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Multicenter Trial to Evaluate Real-world Health Outcomes and Economic Impact of Panitumumab Versus Standard-of-care in the Treatment of Patients With Chemotherapy-refractory Metastatic Colorectal Cancer
Lead sponsor
PeriPharm
Phase
Observational
Overall status
Completed
Start date
April 30, 2014
Completion date
March 31, 2018
Enrollment
72 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic